Go to content
UR Home

The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study

Rosenow, F., Schade-Brittinger, C., Burchardi, N., Arnold, Stephan and LaLiMo Study Group, (2012) The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study. Journal of Neurology, Neurosurgery and Psychiatry 83, pp. 1093-1098.

[img]
Preview
License: Allianz- bzw. Nationallizenz
PDF - Published Version
Download (176kB)
Date of publication of this fulltext: 05 Sep 2017 13:49

at publisher (via DOI)


Abstract

Background: Of the newer antiepileptic drugs, lamotrigine (LTG) and levetiracetam (LEV) are popular first choice drugs for epilepsy. The authors compared these drugs with regard to their efficacy and tolerability in the initial monotherapy for epilepsy. Methods: A randomised, open-label, controlled, parallel group, multicenter trial was conducted to test the superiority of the LEV arm over the ...

plus


Export bibliographical data



Item type:Article
Date:2012
Institutions:Medicine > Lehrstuhl für Neurologie
Identification Number:
ValueType
10.1136/jnnp-2011-301999DOI
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Partially
Item ID:36153
Owner only: item control page

Downloads

Downloads per month over past year

  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons